The first industry sector report on the nature and extent of value creation through human capital is being provided to pharma firms, investors and asset managers. This report into the pharmaceutical sector identifies the key areas where human capital drives value and is most likely to impact on business risk. It also provides ‘Key Questions’ for Boards from an investor perspective with advice on metrics and indicators that provide best insights.
